NYSE · Common Stock · Pharmaceutical Preparations
133 entities across 42 jurisdictions, 8 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Chefaro Ireland Designated Activity Company | Ireland | |
| Elan International Services Limited | Ireland | |
| Omega Teknika Designated Activity Company | Ireland | |
| Perrigo Company plc | Ireland | |
| Perrigo Corporation Designated Activity Company | Ireland | |
| Perrigo Finance Unlimited Company | Ireland | |
| Perrigo Holdings Unlimited Company | Ireland | |
| Perrigo International Finance Designated Activity Company | Ireland | |
| Perrigo Ireland 1 Designated Activity Company | Ireland | |
| Perrigo Ireland 10 Unlimited Company | Ireland | |
| Perrigo Ireland 13 Designated Activity Company | Ireland | |
| Perrigo Ireland 2 Designated Activity Company | Ireland | |
| Perrigo Ireland 4 Unlimited Company | Ireland | |
| Perrigo Pharma International Designated Activity Company | Ireland | |
| Perrigo Science One Designated Activity Company | Ireland | |
| Perrigo Supply Chain International Designated Activity Company | Ireland | |
| L. Perrigo Company | Michigan | |
| Perrigo Americas Holdings, Inc. | Michigan | |
| Perrigo Company | Michigan | |
| Perrigo Finance (US), LLC | Michigan | |
| Perrigo International Holdings, LLC | Michigan | |
| Perrigo International, LLC | Michigan | |
| Perrigo Management Company | Michigan | |
| Perrigo Research & Development Company | Michigan | |
| Perrigo Sales Corporation | Michigan | |
| PMI Branded Pharmaceuticals, Inc. | Michigan | |
| Athena Neurosciences, LLC | Delaware | |
| Elan Pharmaceuticals, LLC | Delaware | |
| HRA Pharma America, Inc. | Delaware | |
| PBM Canada Holdings, LLC | Delaware | |
| PBM Holdings, LLC | Delaware | |
| PBM International Holdings, LLC | Delaware | |
| PBM Mexico Holdings, LLC | Delaware | |
| PBM Mexico Management, LLC | Delaware | |
| PBM Nutritionals, LLC | Delaware | |
| PBM Products, LLC | Delaware | |
| Perrigo China Business Trustee, LLC | Delaware | |
| Perrigo Diabetes Care, LLC | Delaware | |
| Perrigo Investments, LLC | Delaware | |
| Perrigo Mexico Investment Holdings, LLC | Delaware | |
| Perrigo New York, Inc. | Delaware | |
| Perrigo Wisconsin, LLC | Delaware | |
| Perrigo, LLC | Delaware | |
| Ranir Global Holdings, LLC | Delaware | |
| Ranir, LLC | Delaware | |
| SelfCare Holdings, LLC | Delaware | |
| Perrigo Company of Tennessee, Inc. | Tennessee | |
| Perrigo Florida, Inc. | Florida | |
| Perrigo Direct, Inc. | Georgia | |
| Kazmira, LLC | Colorado | |
| Perrigo Israel Opportunities II Ltd. | Israel | |
| Perrigo Israel Trading Limited Partnership | Israel | |
| Galpharm Healthcare Limited | United Kingdom | |
| Galpharm International Limited | United Kingdom | |
| Omega Pharma Limited | United Kingdom | |
| Perrigo Pharma Limited | United Kingdom | |
| Perrigo UK Acquisition Limited | United Kingdom | |
| Perrigo Ventures Limited Partnership | United Kingdom | |
| Ranir (Holdings) Limited | United Kingdom | |
| Ranir Limited | United Kingdom | |
| Solent Oral Care Limited | United Kingdom | |
| Wrafton Laboratories Limited | United Kingdom | |
| PBM Products Mexico S de R.L. de C.V. | Mexico | |
| Perrigo Australia PTY Limited | Australia | |
| Perrigo Laboratories India LLP | India | |
| Omega Pharma GmbH | Austria | |
| Perrigo Österreich GmbH | Austria | |
| Perrigo International Insurance Limited | Bermuda | offshore centre |
| Perrigo Danmark A/S | Denmark | |
| Elan Europa Finance S.á r.l. | Luxembourg | offshore centre |
| HRA NewCo | Luxembourg | offshore centre |
| Monksland Holdings B.V. | Netherlands | |
| Oce-Bio Nederland B.V. | Netherlands | |
| Omega Pharma Nederland B.V. | Netherlands | |
| P-Direct NL B.V. | Netherlands | |
| Perrigo Netherlands B.V. | Netherlands | |
| Perrigo Pharma Holding Nederland BV | Netherlands | |
| Samenwerkende Apothekers Nederland B.V. | Netherlands | |
| Perrigo Malta International Limited | Malta | offshore centre |
| HRA Pharma Switzerland SARL | Switzerland | |
| JLR Pharma S.A. | Switzerland | |
| Perrigo Schweiz AG fka Interdelta S.A. | Switzerland | |
| Perrigo China Business Trust | China | |
| Perrigo Trading (Shanghai) Co., Ltd. | China | |
| Ranir Changshu Oral Care CO., Ltd. | China | |
| Ranir Shenzhen | China | |
| Zibo Xinhua - Perrigo Pharmaceutical Company Ltd. | China | |
| HRA Pharma APAC J.V. | Hong Kong | |
| HRA Pharma Hong Kong Ltd. | Hong Kong | |
| Solent Dental Company Limited | Hong Kong | |
| Perrigo Asia Holding Company Ltd. | Mauritius | offshore centre |
| Perrigo Ukraine, LLC | Ukraine | |
| Medgenix Benelux NV | Belgium | |
| Oce Bio BV | Belgium | |
| Omega Pharma Innovation & Development NV | Belgium | |
| Omega Pharma International NV | Belgium | |
| Omega Pharma Trading NV | Belgium | |
| Perrigo Belgium NV | Belgium | |
| Perrigo Capital NV | Belgium | |
| Perrigo Europe Invest NV | Belgium | |
| Perrigo Holding NV | Belgium | |
| Totalcare International Corp | British Virgin Islands | offshore centre |
| Omega Alpharm Cyprus Ltd. | Cyprus | offshore centre |
| Omega Pharma AS | Czech Republic | |
| Perrigo Suomi Oy | Finland | |
| Cosmediet - Biotechnie SAS | France | |
| HERA SAS | France | |
| Laboratoire de la Mer SAS | France | |
| Laboratoire HRA Pharma SAS | France | |
| Laboratoire Perrigo Pharma France SAS | France | |
| Perrigo France Deux SAS | France | |
| Perrigo France SAS | France | |
| Abtei Omega Pharma GmbH | Germany | |
| Naturwohl Pharma GmbH | Germany | |
| Omega Pharma Manufacturing GmbH & Co. KG | Germany | |
| Omega Pharma Manufacturing Verwaltungs GmbH | Germany | |
| Perrigo Deutschland GmbH | Germany | |
| Perrigo Hellas A.E. | Greece | |
| Despharma Kft. | Hungary | |
| Omega Pharma Hungary Kft. | Hungary | |
| Perrigo Italia S.r.l | Italy | |
| Perrigo IoM Holdings Limited | Isle of Man | offshore centre |
| Perrigo Norge AS | Norway | |
| P. Services International ap z.o.o | Poland | |
| Perrigo Poland Sp z.o.o | Poland | |
| Perrigo Portugal LDA | Portugal | |
| Perrigo Pharma International Designated Activity Company Succursal Em Portugal | Portugal | |
| Perrigo România S.R.L. | Romania | |
| Perrigo España SA | Spain | |
| Aco Hud Nordic AB | Sweden | |
| Perrigo Sverige AB | Sweden | |
| Perrigo Kişisel Bakım Ürünleri Sanayi ve Ticaret Limited Şirketi | Turkey | |
| Perrigo Canada Company, Inc. | Canada |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $5.1B | −$162.6M | $465.8M | 35.9% | 136,100,000 |
| FY2021 | $4.1B | −$68.9M | $4.2M | 34.2% | 133,600,000 |
| FY2022 | $4.5B | −$140.6M | $210.9M | 32.7% | 134,500,000 |
| FY2023 | $4.7B | −$12.7M | $303.8M | 36.1% | 135,300,000 |
| FY2024 | $4.4B | −$171.8M | $244.6M | 35.3% | 137,400,000 |
| FY2025 | $4.3B | −$1.4B | $145.1M | 35.1% | 138,500,000 |
13 institutions tracked — 6 added, 5 reduced, 2 opened a new position. Index money added 8,217,638 shares while active managers cut 3,534,033.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| BlackRock, Inc. | Index | 22,703,127 | +5,583,043 | $235.9M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 8,700,421 | −4,676,355 | $90.4M |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 3,480,666 | +2,797,863 | $35.3M |
| CITADEL ADVISORS LLC | Hedge fund | 391,776 | −1,754,369 | $4.1M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 3,622,308 | +1,331,286 | $37.6M |
| STATE STREET CORP | Index | 8,528,704 | +1,303,309 | $88.7M |
| FMR LLC | Active fund | 394,034 | +368,138 | $4.1M |
| MORGAN STANLEY | Active fund | 2,416,134 | −360,508 | $25.1M |
| Bridgewater Associates, LP | Hedge fund | 324,076 | +198,729 | $3.4M |
| BANK OF AMERICA CORP /DE/ | Active fund | 1,472,007 | −96,591 | $15.3M |
| JPMORGAN CHASE & CO | Active fund | 133,987 | −10,940 | $1.4M |
NORGES BANK, Point72 Asset Management, L.P. hold a position with no prior filing to compare against, so their change is unknown rather than zero — and they are left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
PERRIGO Co plc files under SIC 2834 — all 50 pharmaceutical preparations companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
